Ovid Therapeutics
OVID
OVID
62 hedge funds and large institutions have $110M invested in Ovid Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 67 → 62 (-5)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
Holders
62
Holding in Top 10
1
Calls
$231K
Puts
–
Top Buyers
| 1 | +$1.42M | |
| 2 | +$1.13M | |
| 3 | +$770K | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$691K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$665K |
Top Sellers
| 1 | -$2.46M | |
| 2 | -$288K | |
| 3 | -$251K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$176K |
| 5 |
B
Bailard
Foster City,
California
|
-$154K |